BACKGROUND: With the exception of studies on folic acid, little evidence is available concerning other nutrients in the pathogenesis of congenital heart defects (CHDs). Fatty acids play a central role in embryonic development, and the B-vitamins riboflavin and nicotinamide are co-enzymes in lipid metabolism. AIM OF THE STUDY: To investigate associations between the maternal dietary intake of fats, riboflavin and nicotinamide, and CHD risk in the offspring. METHODS: A case-control family study was conducted in 276 mothers of a child with a CHD comprising of 190 outflow tract defects (OTD) and 86 non-outflow tract defects (non-OTD) and 324 control mothers of a non-malformed child. Mothers filled out general and food frequency questionnaires at 16 months after the index-pregnancy, as a proxy of the habitual food intake in the preconception period. Nutrient intakes (medians) were compared between cases and controls by Mann-Whitney U test. Odds ratios (OR) for the association between CHDs and nutrient intakes were estimated in a logistic regression model. RESULTS: Case mothers, in particular mothers of a child with OTD, had higher dietary intakes of saturated fat, 30.9 vs. 29.8 g/d; P < 0.05. Dietary intakes of riboflavin and nicotinamide were lower in mothers of a child with an OTD than in controls (1.32 vs. 1.41 mg/d; P < 0.05 and 14.6 vs. 15.1 mg/d; P < 0.05, respectively). Energy, unsaturated fat, cholesterol and folate intakes were comparable between the groups. Low dietary intakes of both riboflavin (<1.20 mg/d) and nicotinamide (<13.5 mg/d) increased more than two-fold the risk of a child with an OTD, especially in mothers who did not use vitamin supplements in the periconceptional period (OR 2.4, 95%CI 1.4-4.0). Increasing intakes of nicotinamide (OR 0.8, 95%CI 0.7-1.001, per unit standard deviation increase) decreased CHD risk independent of dietary folate intake. CONCLUSIONS: A maternal diet high in saturated fats and low in riboflavin and nicotinamide seems to contribute to CHD risk, in particular OTDs.
BACKGROUND: With the exception of studies on folic acid, little evidence is available concerning other nutrients in the pathogenesis of congenital heart defects (CHDs). Fatty acids play a central role in embryonic development, and the B-vitamins riboflavin and nicotinamide are co-enzymes in lipid metabolism. AIM OF THE STUDY: To investigate associations between the maternal dietary intake of fats, riboflavin and nicotinamide, and CHD risk in the offspring. METHODS: A case-control family study was conducted in 276 mothers of a child with a CHD comprising of 190 outflow tract defects (OTD) and 86 non-outflow tract defects (non-OTD) and 324 control mothers of a non-malformed child. Mothers filled out general and food frequency questionnaires at 16 months after the index-pregnancy, as a proxy of the habitual food intake in the preconception period. Nutrient intakes (medians) were compared between cases and controls by Mann-Whitney U test. Odds ratios (OR) for the association between CHDs and nutrient intakes were estimated in a logistic regression model. RESULTS: Case mothers, in particular mothers of a child with OTD, had higher dietary intakes of saturated fat, 30.9 vs. 29.8 g/d; P < 0.05. Dietary intakes of riboflavin and nicotinamide were lower in mothers of a child with an OTD than in controls (1.32 vs. 1.41 mg/d; P < 0.05 and 14.6 vs. 15.1 mg/d; P < 0.05, respectively). Energy, unsaturated fat, cholesterol and folate intakes were comparable between the groups. Low dietary intakes of both riboflavin (<1.20 mg/d) and nicotinamide (<13.5 mg/d) increased more than two-fold the risk of a child with an OTD, especially in mothers who did not use vitamin supplements in the periconceptional period (OR 2.4, 95%CI 1.4-4.0). Increasing intakes of nicotinamide (OR 0.8, 95%CI 0.7-1.001, per unit standard deviation increase) decreased CHD risk independent of dietary folate intake. CONCLUSIONS: A maternal diet high in saturated fats and low in riboflavin and nicotinamide seems to contribute to CHD risk, in particular OTDs.
Authors: Charlotte A Hobbs; Sadia Malik; Weizhi Zhao; S Jill James; Stepan Melnyk; Mario A Cleves Journal: J Am Coll Cardiol Date: 2006-01-18 Impact factor: 24.094
Authors: G R Goldberg; A E Black; S A Jebb; T J Cole; P R Murgatroyd; W A Coward; A M Prentice Journal: Eur J Clin Nutr Date: 1991-12 Impact factor: 4.016
Authors: Anna C Verkleij-Hagoort; Jeanne H M de Vries; Nicolette T C Ursem; Robert de Jonge; Wim C J Hop; Régine P M Steegers-Theunissen Journal: Eur J Nutr Date: 2006-11-21 Impact factor: 5.614
Authors: Margaret L Watkins; Sonja A Rasmussen; Margaret A Honein; Lorenzo D Botto; Cynthia A Moore Journal: Pediatrics Date: 2003-05 Impact factor: 7.124
Authors: Ingrid P C Krapels; Iris A L M van Rooij; Marga C Ocké; Brigitte A G L van Cleef; Anne-Marie M Kuijpers-Jagtman; Régine P M Steegers-Theunissen Journal: Eur J Nutr Date: 2004-01-06 Impact factor: 5.614
Authors: Veedamali S Subramanian; Subrata Sabui; Trevor Teafatiller; Jennifer A Bohl; Hamid M Said Journal: Am J Physiol Cell Physiol Date: 2017-06-21 Impact factor: 4.249
Authors: Nastaran Salavati; Marian K Bakker; Fraser Lewis; Petra C Vinke; Farya Mubarik; JanJaap H M Erwich; Eline M van der Beek Journal: PLoS One Date: 2020-12-02 Impact factor: 3.240